Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F
暂无分享,去创建一个
Y. Zuo | Si-Zhe Li | Xin-Xing Jin | Xiao-Lei Ge | H. Jin
[1] K. Johnell,et al. Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: a cohort study. , 2020, Journal of the American Academy of Dermatology.
[2] L. Xiaowei,et al. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.
[3] H. Shimizu,et al. Regulatory T‐cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects , 2018, The Journal of allergy and clinical immunology.
[4] B. Li,et al. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis , 2018, BMC Complementary and Alternative Medicine.
[5] Xin Chen,et al. Effects of Tripterygium wilfordii Induction Therapy to IgA Nephropathy Patients with Heavy Proteinuria. , 2017, Biological & pharmaceutical bulletin.
[6] Xiaojun Zhang,et al. Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats , 2017, Evidence-based complementary and alternative medicine : eCAM.
[7] Xiaoyan Xiao,et al. Huang Gan Formula Eliminates the Oxidative Stress Effects of Advanced Oxidation Protein Products on the Divergent Regulation of the Expression of AGEs Receptors via the JAK2/STAT3 Pathway , 2017, Evidence-based complementary and alternative medicine : eCAM.
[8] Xiaoyan Wu,et al. Tripterygium wilfordii polyglycosidium ameliorates pouchitis induced by dextran sulfate sodium in rats , 2017, International immunopharmacology.
[9] T. Ruzicka,et al. Bullous pemphigoid. , 2017, Autoimmunity reviews.
[10] L. Ye,et al. Effect of Tripterygium Wilfordii Polyglycoside on Experimental Prostatitis Caused by Ureaplasma Urealyticum in Rats , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[11] Y. Ma,et al. Effects of Tripterygium wilfordii glycosides on regulatory T cells and Th17 in an IgA nephropathy rat model. , 2015, Genetics and molecular research : GMR.
[12] D. Zillikens,et al. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[13] D. Zillikens,et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology , 2015, The British journal of dermatology.
[14] P. Lipsky,et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial , 2014, Annals of the rheumatic diseases.
[15] Baoxi Wang,et al. Treatment of coexisting bullous pemphigoid and psoriasis with triptergium wilfordii. , 2014, Chinese medical journal.
[16] R. Wolf,et al. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies. , 2013, Clinics in dermatology.
[17] Yunzhao Zhao,et al. Prevention of postoperative recurrence of Crohn’s disease: Tripterygium wilfordii polyglycoside versus mesalazine , 2013, The Journal of international medical research.
[18] M. Mustapa,et al. British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012 , 2012, The British journal of dermatology.
[19] Yonglong Yan,et al. Triptolide regulates T cell-mediated immunity via induction of CD11c(low) dendritic cell differentiation. , 2012, Food and Chemical Toxicology.
[20] H. Shimizu,et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. , 2012, Journal of the American Academy of Dermatology.